PubMed:18046082
Annnotations
LitCoin-entities
| Id | Subject | Object | Predicate | Lexical cue | db_id |
|---|---|---|---|---|---|
| 4550 | 18-34 | GeneOrGeneProduct | denotes | apolipoprotein E | NCBIGene:348 |
| 4551 | 46-66 | SequenceVariant | denotes | arginine 150 proline | p|SUB|R|150|P |
| 4552 | 99-125 | DiseaseOrPhenotypicFeature | denotes | lipoprotein glomerulopathy | MESH:C567089 |
| 4553 | 144-170 | DiseaseOrPhenotypicFeature | denotes | Lipoprotein glomerulopathy | MESH:C567089 |
| 4554 | 172-175 | DiseaseOrPhenotypicFeature | denotes | LPG | MESH:C567089 |
| 4555 | 212-220 | DiseaseOrPhenotypicFeature | denotes | thrombus | MESH:D013927 |
| 4556 | 249-279 | DiseaseOrPhenotypicFeature | denotes | dilated glomerular capillaries | MESH:D007674 |
| 4557 | 310-326 | GeneOrGeneProduct | denotes | apolipoprotein E | NCBIGene:348 |
| 4558 | 328-332 | GeneOrGeneProduct | denotes | apoE | NCBIGene:348 |
| 4559 | 389-393 | GeneOrGeneProduct | denotes | apoE | NCBIGene:348 |
| 4560 | 432-435 | DiseaseOrPhenotypicFeature | denotes | LPG | MESH:C567089 |
| 4561 | 441-444 | DiseaseOrPhenotypicFeature | denotes | LPG | MESH:C567089 |
| 4562 | 466-470 | GeneOrGeneProduct | denotes | apoE | NCBIGene:348 |
| 4563 | 497-505 | OrganismTaxon | denotes | patients | NCBITaxon:9606 |
| 4564 | 567-571 | GeneOrGeneProduct | denotes | apoE | NCBIGene:348 |
| 4565 | 577-580 | DiseaseOrPhenotypicFeature | denotes | LPG | MESH:C567089 |
| 4566 | 615-619 | GeneOrGeneProduct | denotes | apoE | NCBIGene:348 |
| 4567 | 644-647 | DiseaseOrPhenotypicFeature | denotes | LPG | MESH:C567089 |
| 4568 | 648-656 | OrganismTaxon | denotes | patients | NCBITaxon:9606 |
| 4569 | 730-734 | GeneOrGeneProduct | denotes | apoE | NCBIGene:348 |
| 4570 | 843-847 | GeneOrGeneProduct | denotes | apoE | NCBIGene:348 |
| 4571 | 877-880 | DiseaseOrPhenotypicFeature | denotes | LPG | MESH:C567089 |
| 4572 | 881-889 | OrganismTaxon | denotes | patients | NCBITaxon:9606 |
| 4573 | 965-1007 | SequenceVariant | denotes | G to C point mutation in exon 4 (base 308) | c|SUB|G|308|C |
| 4574 | 1015-1019 | GeneOrGeneProduct | denotes | apoE | NCBIGene:348 |
| 4575 | 1032-1040 | OrganismTaxon | denotes | patients | NCBITaxon:9606 |
| 4576 | 1139-1191 | SequenceVariant | denotes | proline residue for arginine residue at position 150 | p|SUB|R|150|P |
| 4577 | 1195-1199 | GeneOrGeneProduct | denotes | apoE | NCBIGene:348 |
| 4578 | 1207-1215 | OrganismTaxon | denotes | patients | NCBITaxon:9606 |
| 4579 | 1244-1248 | GeneOrGeneProduct | denotes | apoE | NCBIGene:348 |
| 4580 | 1309-1313 | GeneOrGeneProduct | denotes | apoE | NCBIGene:348 |
| 4581 | 1350-1361 | DiseaseOrPhenotypicFeature | denotes | proteinuria | MESH:D011507 |
| 4582 | 1414-1418 | GeneOrGeneProduct | denotes | apoE | NCBIGene:348 |
| 4583 | 1420-1440 | SequenceVariant | denotes | arginine 150 proline | p|SUB|R|150|P |
| 4584 | 1453-1457 | GeneOrGeneProduct | denotes | apoE | NCBIGene:348 |
| 4585 | 1496-1499 | DiseaseOrPhenotypicFeature | denotes | LPG | MESH:C567089 |
| 4586 | 1515-1519 | GeneOrGeneProduct | denotes | apoE | NCBIGene:348 |
| 4587 | 1589-1593 | GeneOrGeneProduct | denotes | apoE | NCBIGene:348 |
| 4588 | 1633-1639 | ChemicalEntity | denotes | lipids | MESH:D008055 |
LitCoin-sentences
| Id | Subject | Object | Predicate | Lexical cue |
|---|---|---|---|---|
| T1 | 0-126 | Sentence | denotes | Identification of apolipoprotein E Guangzhou (arginine 150 proline), a new variant associated with lipoprotein glomerulopathy. |
| T2 | 127-143 | Sentence | denotes | BACKGROUND/AIMS: |
| T3 | 144-334 | Sentence | denotes | Lipoprotein glomerulopathy (LPG) is a rare disease characterized by thrombus-like substances in markedly dilated glomerular capillaries and elevated plasma levels of apolipoprotein E (apoE). |
| T4 | 335-506 | Sentence | denotes | Previous studies have shown that genetic disorders of apoE may contribute to the pathogenesis of LPG, but LPG may not be caused by apoE gene mutations in Chinese patients. |
| T5 | 507-601 | Sentence | denotes | This study investigated the association of a new variant of apoE with LPG in a Chinese family. |
| T6 | 602-610 | Sentence | denotes | METHODS: |
| T7 | 611-671 | Sentence | denotes | The apoE gene in a family with 4 LPG patients was sequenced. |
| T8 | 672-793 | Sentence | denotes | The polymerase chain reaction product of coding region of apoE exon 4 was cloned into pMD 18-T vector and then sequenced. |
| T9 | 794-802 | Sentence | denotes | RESULTS: |
| T10 | 803-923 | Sentence | denotes | A novel point mutation in exon 4 of the apoE gene was identified in all 4 LPG patients and 1 asymptomatic family member. |
| T11 | 924-1076 | Sentence | denotes | Sequence analysis confirmed a nucleotide G to C point mutation in exon 4 (base 308) of the apoE gene in all patients and the asymptomatic family member. |
| T12 | 1077-1200 | Sentence | denotes | This missense mutation denotes amino acid substitution of the proline residue for arginine residue at position 150 of apoE. |
| T13 | 1201-1259 | Sentence | denotes | Those patients were all heterozygotes with apoE Guangzhou. |
| T14 | 1260-1362 | Sentence | denotes | One of 2 grandsons was a heterozygous carrier of apoE Guangzhou, although he did not have proteinuria. |
| T15 | 1363-1374 | Sentence | denotes | CONCLUSION: |
| T16 | 1375-1500 | Sentence | denotes | The results of this study suggest that apoE (arginine 150 proline) is a novel apoE variant that etiologically related to LPG. |
| T17 | 1501-1640 | Sentence | denotes | This variant (apoE Guangzhou) may cause a marked molecular conformational change of the apoE and thus impair its binding ability to lipids. |
LitCoin-entities-OrganismTaxon-PD
| Id | Subject | Object | Predicate | Lexical cue | db_id |
|---|---|---|---|---|---|
| T1 | 212-220 | OrganismTaxon | denotes | thrombus | NCBItxid:1006837 |
PMID_GLOBAL
| Id | Subject | Object | Predicate | Lexical cue | mondo_id |
|---|---|---|---|---|---|
| T1 | 99-125 | DiseaseOrPhenotypicFeature | denotes | lipoprotein glomerulopathy | 0012725 |
| T2 | 144-170 | DiseaseOrPhenotypicFeature | denotes | Lipoprotein glomerulopathy | 0012725 |
| T3 | 172-175 | DiseaseOrPhenotypicFeature | denotes | LPG | 0012725 |
| T4 | 212-220 | DiseaseOrPhenotypicFeature | denotes | thrombus | 0000831 |
| T5 | 368-385 | DiseaseOrPhenotypicFeature | denotes | genetic disorders | 0003847 |
| T6 | 432-435 | DiseaseOrPhenotypicFeature | denotes | LPG | 0012725 |
| T7 | 441-444 | DiseaseOrPhenotypicFeature | denotes | LPG | 0012725 |
| T8 | 577-580 | DiseaseOrPhenotypicFeature | denotes | LPG | 0012725 |
| T9 | 644-647 | DiseaseOrPhenotypicFeature | denotes | LPG | 0012725 |
| T10 | 877-880 | DiseaseOrPhenotypicFeature | denotes | LPG | 0012725 |
| T11 | 1334-1336 | DiseaseOrPhenotypicFeature | denotes | he | 0017319 |
| T12 | 1350-1361 | DiseaseOrPhenotypicFeature | denotes | proteinuria | 0003634 |
| T13 | 1496-1499 | DiseaseOrPhenotypicFeature | denotes | LPG | 0012725 |
LitCoin_Mondo
| Id | Subject | Object | Predicate | Lexical cue | mondo_id |
|---|---|---|---|---|---|
| T1 | 99-125 | DiseaseOrPhenotypicFeature | denotes | lipoprotein glomerulopathy | 0012725 |
| T2 | 144-170 | DiseaseOrPhenotypicFeature | denotes | Lipoprotein glomerulopathy | 0012725 |
| T3 | 182-186 | DiseaseOrPhenotypicFeature | denotes | rare | 0021136 |
| T4 | 1350-1361 | DiseaseOrPhenotypicFeature | denotes | proteinuria | 0003634 |
LitCoin-SeqVar
| Id | Subject | Object | Predicate | Lexical cue |
|---|---|---|---|---|
| T1 | 762-766 | SequenceVariant | denotes | 18-T |
LitCoin-GeneOrGeneProduct-v0
| Id | Subject | Object | Predicate | Lexical cue |
|---|---|---|---|---|
| T1 | 18-34 | GeneOrGeneProduct | denotes | apolipoprotein E |
| T2 | 99-110 | GeneOrGeneProduct | denotes | lipoprotein |
| T3 | 144-155 | GeneOrGeneProduct | denotes | Lipoprotein |
| T4 | 182-186 | GeneOrGeneProduct | denotes | rare |
| T5 | 221-225 | GeneOrGeneProduct | denotes | like |
| T6 | 240-248 | GeneOrGeneProduct | denotes | markedly |
| T7 | 310-326 | GeneOrGeneProduct | denotes | apolipoprotein E |
| T8 | 328-332 | GeneOrGeneProduct | denotes | apoE |
| T9 | 389-393 | GeneOrGeneProduct | denotes | apoE |
| T10 | 466-470 | GeneOrGeneProduct | denotes | apoE |
| T11 | 476-485 | GeneOrGeneProduct | denotes | mutations |
| T12 | 567-571 | GeneOrGeneProduct | denotes | apoE |
| T13 | 581-585 | GeneOrGeneProduct | denotes | in a |
| T14 | 602-609 | GeneOrGeneProduct | denotes | METHODS |
| T15 | 615-619 | GeneOrGeneProduct | denotes | apoE |
| T16 | 620-629 | GeneOrGeneProduct | denotes | gene in a |
| T17 | 676-686 | GeneOrGeneProduct | denotes | polymerase |
| T18 | 687-692 | GeneOrGeneProduct | denotes | chain |
| T19 | 702-709 | GeneOrGeneProduct | denotes | product |
| T20 | 730-734 | GeneOrGeneProduct | denotes | apoE |
| T21 | 746-752 | GeneOrGeneProduct | denotes | cloned |
| T22 | 805-810 | GeneOrGeneProduct | denotes | novel |
| T23 | 811-816 | GeneOrGeneProduct | denotes | point |
| T24 | 817-825 | GeneOrGeneProduct | denotes | mutation |
| T25 | 843-847 | GeneOrGeneProduct | denotes | apoE |
| T26 | 871-874 | GeneOrGeneProduct | denotes | all |
| T27 | 890-895 | GeneOrGeneProduct | denotes | and 1 |
| T28 | 972-977 | GeneOrGeneProduct | denotes | point |
| T29 | 978-986 | GeneOrGeneProduct | denotes | mutation |
| T30 | 998-1002 | GeneOrGeneProduct | denotes | base |
| T31 | 1015-1019 | GeneOrGeneProduct | denotes | apoE |
| T32 | 1028-1031 | GeneOrGeneProduct | denotes | all |
| T33 | 1082-1090 | GeneOrGeneProduct | denotes | missense |
| T34 | 1091-1099 | GeneOrGeneProduct | denotes | mutation |
| T35 | 1108-1118 | GeneOrGeneProduct | denotes | amino acid |
| T36 | 1195-1199 | GeneOrGeneProduct | denotes | apoE |
| T37 | 1221-1224 | GeneOrGeneProduct | denotes | all |
| T38 | 1244-1248 | GeneOrGeneProduct | denotes | apoE |
| T39 | 1298-1305 | GeneOrGeneProduct | denotes | carrier |
| T40 | 1309-1313 | GeneOrGeneProduct | denotes | apoE |
| T41 | 1414-1418 | GeneOrGeneProduct | denotes | apoE |
| T42 | 1447-1452 | GeneOrGeneProduct | denotes | novel |
| T43 | 1453-1457 | GeneOrGeneProduct | denotes | apoE |
| T44 | 1515-1519 | GeneOrGeneProduct | denotes | apoE |
| T45 | 1543-1549 | GeneOrGeneProduct | denotes | marked |
| T46 | 1589-1593 | GeneOrGeneProduct | denotes | apoE |
| T47 | 1614-1621 | GeneOrGeneProduct | denotes | binding |
LitCoin-GeneOrGeneProduct-v2
| Id | Subject | Object | Predicate | Lexical cue |
|---|---|---|---|---|
| T1 | 18-34 | GeneOrGeneProduct | denotes | apolipoprotein E |
| T2 | 99-110 | GeneOrGeneProduct | denotes | lipoprotein |
| T3 | 144-155 | GeneOrGeneProduct | denotes | Lipoprotein |
| T4 | 182-186 | GeneOrGeneProduct | denotes | rare |
| T5 | 221-225 | GeneOrGeneProduct | denotes | like |
| T6 | 310-326 | GeneOrGeneProduct | denotes | apolipoprotein E |
| T7 | 328-332 | GeneOrGeneProduct | denotes | apoE |
| T8 | 389-393 | GeneOrGeneProduct | denotes | apoE |
| T9 | 466-470 | GeneOrGeneProduct | denotes | apoE |
| T10 | 567-571 | GeneOrGeneProduct | denotes | apoE |
| T11 | 615-619 | GeneOrGeneProduct | denotes | apoE |
| T12 | 676-686 | GeneOrGeneProduct | denotes | polymerase |
| T13 | 687-692 | GeneOrGeneProduct | denotes | chain |
| T14 | 702-709 | GeneOrGeneProduct | denotes | product |
| T15 | 730-734 | GeneOrGeneProduct | denotes | apoE |
| T16 | 805-810 | GeneOrGeneProduct | denotes | novel |
| T17 | 843-847 | GeneOrGeneProduct | denotes | apoE |
| T18 | 890-895 | GeneOrGeneProduct | denotes | and 1 |
| T19 | 1015-1019 | GeneOrGeneProduct | denotes | apoE |
| T20 | 1108-1118 | GeneOrGeneProduct | denotes | amino acid |
| T21 | 1195-1199 | GeneOrGeneProduct | denotes | apoE |
| T22 | 1244-1248 | GeneOrGeneProduct | denotes | apoE |
| T23 | 1298-1305 | GeneOrGeneProduct | denotes | carrier |
| T24 | 1309-1313 | GeneOrGeneProduct | denotes | apoE |
| T25 | 1414-1418 | GeneOrGeneProduct | denotes | apoE |
| T26 | 1447-1452 | GeneOrGeneProduct | denotes | novel |
| T27 | 1453-1457 | GeneOrGeneProduct | denotes | apoE |
| T28 | 1515-1519 | GeneOrGeneProduct | denotes | apoE |
| T29 | 1589-1593 | GeneOrGeneProduct | denotes | apoE |
| T30 | 1614-1621 | GeneOrGeneProduct | denotes | binding |
LitCoin-Disease-MeSH
| Id | Subject | Object | Predicate | Lexical cue | originalLabel |
|---|---|---|---|---|---|
| T1 | 99-125 | DiseaseOrPhenotypicFeature | denotes | lipoprotein glomerulopathy | C567089 |
| T2 | 144-170 | DiseaseOrPhenotypicFeature | denotes | Lipoprotein glomerulopathy | C567089 |
| T3 | 172-175 | DiseaseOrPhenotypicFeature | denotes | LPG | C567089 |
| T4 | 182-194 | DiseaseOrPhenotypicFeature | denotes | rare disease | D035583 |
| T5 | 212-220 | DiseaseOrPhenotypicFeature | denotes | thrombus | D013927 |
| T6 | 368-385 | DiseaseOrPhenotypicFeature | denotes | genetic disorders | D030342 |
| T7 | 432-435 | DiseaseOrPhenotypicFeature | denotes | LPG | C567089 |
| T8 | 441-444 | DiseaseOrPhenotypicFeature | denotes | LPG | C567089 |
| T9 | 577-580 | DiseaseOrPhenotypicFeature | denotes | LPG | C567089 |
| T10 | 644-647 | DiseaseOrPhenotypicFeature | denotes | LPG | C567089 |
| T11 | 877-880 | DiseaseOrPhenotypicFeature | denotes | LPG | C567089 |
| T12 | 1350-1361 | DiseaseOrPhenotypicFeature | denotes | proteinuria | D011507 |
| T13 | 1496-1499 | DiseaseOrPhenotypicFeature | denotes | LPG | C567089 |
LitCoin-GeneOrGeneProduct-v3
| Id | Subject | Object | Predicate | Lexical cue |
|---|---|---|---|---|
| T1 | 18-34 | GeneOrGeneProduct | denotes | apolipoprotein E |
| T2 | 99-110 | GeneOrGeneProduct | denotes | lipoprotein |
| T3 | 144-155 | GeneOrGeneProduct | denotes | Lipoprotein |
| T4 | 310-326 | GeneOrGeneProduct | denotes | apolipoprotein E |
| T5 | 328-332 | GeneOrGeneProduct | denotes | apoE |
| T6 | 389-393 | GeneOrGeneProduct | denotes | apoE |
| T7 | 466-470 | GeneOrGeneProduct | denotes | apoE |
| T8 | 567-571 | GeneOrGeneProduct | denotes | apoE |
| T9 | 615-619 | GeneOrGeneProduct | denotes | apoE |
| T10 | 730-734 | GeneOrGeneProduct | denotes | apoE |
| T11 | 843-847 | GeneOrGeneProduct | denotes | apoE |
| T12 | 1015-1019 | GeneOrGeneProduct | denotes | apoE |
| T13 | 1195-1199 | GeneOrGeneProduct | denotes | apoE |
| T14 | 1244-1248 | GeneOrGeneProduct | denotes | apoE |
| T15 | 1309-1313 | GeneOrGeneProduct | denotes | apoE |
| T16 | 1414-1418 | GeneOrGeneProduct | denotes | apoE |
| T17 | 1453-1457 | GeneOrGeneProduct | denotes | apoE |
| T18 | 1515-1519 | GeneOrGeneProduct | denotes | apoE |
| T19 | 1589-1593 | GeneOrGeneProduct | denotes | apoE |
LitCoin_Mondo_095
| Id | Subject | Object | Predicate | Lexical cue | mondo_id |
|---|---|---|---|---|---|
| T1 | 99-125 | DiseaseOrPhenotypicFeature | denotes | lipoprotein glomerulopathy | 0012725 |
| T2 | 144-170 | DiseaseOrPhenotypicFeature | denotes | Lipoprotein glomerulopathy | 0012725 |
| T3 | 172-175 | DiseaseOrPhenotypicFeature | denotes | LPG | 0012725 |
| T4 | 212-220 | DiseaseOrPhenotypicFeature | denotes | thrombus | 0000831 |
| T5 | 368-385 | DiseaseOrPhenotypicFeature | denotes | genetic disorders | 0003847 |
| T6 | 432-435 | DiseaseOrPhenotypicFeature | denotes | LPG | 0012725 |
| T7 | 441-444 | DiseaseOrPhenotypicFeature | denotes | LPG | 0012725 |
| T8 | 577-580 | DiseaseOrPhenotypicFeature | denotes | LPG | 0012725 |
| T9 | 644-647 | DiseaseOrPhenotypicFeature | denotes | LPG | 0012725 |
| T10 | 877-880 | DiseaseOrPhenotypicFeature | denotes | LPG | 0012725 |
| T11 | 1334-1336 | DiseaseOrPhenotypicFeature | denotes | he | 0017319 |
| T12 | 1350-1361 | DiseaseOrPhenotypicFeature | denotes | proteinuria | 0003634 |
| T13 | 1496-1499 | DiseaseOrPhenotypicFeature | denotes | LPG | 0012725 |
LitCoin-MeSH-Disease-2
| Id | Subject | Object | Predicate | Lexical cue | ID: |
|---|---|---|---|---|---|
| T1 | 99-125 | DiseaseOrPhenotypicFeature | denotes | lipoprotein glomerulopathy | C567089 |
| T2 | 144-170 | DiseaseOrPhenotypicFeature | denotes | Lipoprotein glomerulopathy | C567089 |
| T3 | 172-175 | DiseaseOrPhenotypicFeature | denotes | LPG | C567089 |
| T4 | 182-194 | DiseaseOrPhenotypicFeature | denotes | rare disease | D035583 |
| T5 | 212-220 | DiseaseOrPhenotypicFeature | denotes | thrombus | D013927 |
| T6 | 249-279 | DiseaseOrPhenotypicFeature | denotes | dilated glomerular capillaries | DISEASE |
| T7 | 368-385 | DiseaseOrPhenotypicFeature | denotes | genetic disorders | D030342 |
| T8 | 432-435 | DiseaseOrPhenotypicFeature | denotes | LPG | C567089 |
| T9 | 441-444 | DiseaseOrPhenotypicFeature | denotes | LPG | C567089 |
| T10 | 577-580 | DiseaseOrPhenotypicFeature | denotes | LPG | C567089 |
| T11 | 644-647 | DiseaseOrPhenotypicFeature | denotes | LPG | C567089 |
| T12 | 877-880 | DiseaseOrPhenotypicFeature | denotes | LPG | C567089 |
| T13 | 1350-1361 | DiseaseOrPhenotypicFeature | denotes | proteinuria | D011507 |
| T14 | 1496-1499 | DiseaseOrPhenotypicFeature | denotes | LPG | C567089 |
LitCoin-MONDO_bioort2019
| Id | Subject | Object | Predicate | Lexical cue | #label |
|---|---|---|---|---|---|
| T1 | 99-125 | DiseaseOrPhenotypicFeature | denotes | lipoprotein glomerulopathy | C567089 |
| T2 | 144-170 | DiseaseOrPhenotypicFeature | denotes | Lipoprotein glomerulopathy | C567089 |
| T3 | 172-175 | DiseaseOrPhenotypicFeature | denotes | LPG | C567089 |
| T4 | 212-220 | DiseaseOrPhenotypicFeature | denotes | thrombus | D013927 |
| T5 | 432-435 | DiseaseOrPhenotypicFeature | denotes | LPG | C567089 |
| T6 | 441-444 | DiseaseOrPhenotypicFeature | denotes | LPG | C567089 |
| T7 | 577-580 | DiseaseOrPhenotypicFeature | denotes | LPG | C567089 |
| T8 | 644-647 | DiseaseOrPhenotypicFeature | denotes | LPG | C567089 |
| T9 | 877-880 | DiseaseOrPhenotypicFeature | denotes | LPG | C567089 |
| T10 | 1350-1361 | DiseaseOrPhenotypicFeature | denotes | proteinuria | D011507 |
| T11 | 1496-1499 | DiseaseOrPhenotypicFeature | denotes | LPG | C567089 |
LitCoin-Chemical-MeSH-CHEBI
| Id | Subject | Object | Predicate | Lexical cue | ID: |
|---|---|---|---|---|---|
| T1 | 18-32 | ChemicalEntity | denotes | apolipoprotein | http://purl.obolibrary.org/obo/CHEBI_39015 |
| T2 | 46-54 | ChemicalEntity | denotes | arginine | http://purl.obolibrary.org/obo/CHEBI_32696|http://purl.obolibrary.org/obo/CHEBI_29016|http://purl.obolibrary.org/obo/CHEBI_16467 |
| T5 | 59-66 | ChemicalEntity | denotes | proline | http://purl.obolibrary.org/obo/CHEBI_26271|http://purl.obolibrary.org/obo/CHEBI_17203 |
| T7 | 172-175 | ChemicalEntity | denotes | LPG | http://purl.obolibrary.org/obo/CHEBI_59681 |
| T8 | 310-324 | ChemicalEntity | denotes | apolipoprotein | http://purl.obolibrary.org/obo/CHEBI_39015 |
| T9 | 432-435 | ChemicalEntity | denotes | LPG | http://purl.obolibrary.org/obo/CHEBI_59681 |
| T10 | 441-444 | ChemicalEntity | denotes | LPG | http://purl.obolibrary.org/obo/CHEBI_59681 |
| T11 | 577-580 | ChemicalEntity | denotes | LPG | http://purl.obolibrary.org/obo/CHEBI_59681 |
| T12 | 644-647 | ChemicalEntity | denotes | LPG | http://purl.obolibrary.org/obo/CHEBI_59681 |
| T13 | 877-880 | ChemicalEntity | denotes | LPG | http://purl.obolibrary.org/obo/CHEBI_59681 |
| T14 | 1139-1154 | ChemicalEntity | denotes | proline residue | http://purl.obolibrary.org/obo/CHEBI_32874 |
| T15 | 1159-1175 | ChemicalEntity | denotes | arginine residue | http://purl.obolibrary.org/obo/CHEBI_32700 |
| T16 | 1420-1428 | ChemicalEntity | denotes | arginine | http://purl.obolibrary.org/obo/CHEBI_32696|http://purl.obolibrary.org/obo/CHEBI_29016|http://purl.obolibrary.org/obo/CHEBI_16467 |
| T19 | 1433-1440 | ChemicalEntity | denotes | proline | http://purl.obolibrary.org/obo/CHEBI_26271|http://purl.obolibrary.org/obo/CHEBI_17203 |
| T21 | 1496-1499 | ChemicalEntity | denotes | LPG | http://purl.obolibrary.org/obo/CHEBI_59681 |
LitCoin-NCBITaxon-2
| Id | Subject | Object | Predicate | Lexical cue |
|---|---|---|---|---|
| T1 | 212-220 | OrganismTaxon | denotes | thrombus |
| T2 | 497-505 | OrganismTaxon | denotes | patients |
| T3 | 648-656 | OrganismTaxon | denotes | patients |
| T4 | 881-889 | OrganismTaxon | denotes | patients |
| T5 | 1032-1040 | OrganismTaxon | denotes | patients |
| T6 | 1207-1215 | OrganismTaxon | denotes | patients |
LitCoin-training-merged
| Id | Subject | Object | Predicate | Lexical cue | #label | ID: |
|---|---|---|---|---|---|---|
| T21 | 1496-1499 | ChemicalEntity | denotes | LPG | http://purl.obolibrary.org/obo/CHEBI_59681 | |
| T19 | 1433-1440 | ChemicalEntity | denotes | proline | http://purl.obolibrary.org/obo/CHEBI_17203|http://purl.obolibrary.org/obo/CHEBI_26271 | |
| T16 | 1420-1428 | ChemicalEntity | denotes | arginine | http://purl.obolibrary.org/obo/CHEBI_16467|http://purl.obolibrary.org/obo/CHEBI_29016|http://purl.obolibrary.org/obo/CHEBI_32696 | |
| T15 | 1159-1175 | ChemicalEntity | denotes | arginine residue | http://purl.obolibrary.org/obo/CHEBI_32700 | |
| T14 | 1139-1154 | ChemicalEntity | denotes | proline residue | http://purl.obolibrary.org/obo/CHEBI_32874 | |
| T13 | 877-880 | ChemicalEntity | denotes | LPG | http://purl.obolibrary.org/obo/CHEBI_59681 | |
| T12 | 644-647 | ChemicalEntity | denotes | LPG | http://purl.obolibrary.org/obo/CHEBI_59681 | |
| T11 | 577-580 | ChemicalEntity | denotes | LPG | http://purl.obolibrary.org/obo/CHEBI_59681 | |
| T10 | 441-444 | ChemicalEntity | denotes | LPG | http://purl.obolibrary.org/obo/CHEBI_59681 | |
| T9 | 432-435 | ChemicalEntity | denotes | LPG | http://purl.obolibrary.org/obo/CHEBI_59681 | |
| T8 | 310-324 | ChemicalEntity | denotes | apolipoprotein | http://purl.obolibrary.org/obo/CHEBI_39015 | |
| T7 | 172-175 | ChemicalEntity | denotes | LPG | http://purl.obolibrary.org/obo/CHEBI_59681 | |
| T5 | 59-66 | ChemicalEntity | denotes | proline | http://purl.obolibrary.org/obo/CHEBI_17203|http://purl.obolibrary.org/obo/CHEBI_26271 | |
| T2 | 46-54 | ChemicalEntity | denotes | arginine | http://purl.obolibrary.org/obo/CHEBI_16467|http://purl.obolibrary.org/obo/CHEBI_29016|http://purl.obolibrary.org/obo/CHEBI_32696 | |
| T1 | 18-32 | ChemicalEntity | denotes | apolipoprotein | http://purl.obolibrary.org/obo/CHEBI_39015 | |
| T14222 | 1589-1593 | GeneOrGeneProduct | denotes | apoE | ||
| T18 | 1515-1519 | GeneOrGeneProduct | denotes | apoE | ||
| T17 | 1453-1457 | GeneOrGeneProduct | denotes | apoE | ||
| T40089 | 1414-1418 | GeneOrGeneProduct | denotes | apoE | ||
| T52355 | 1309-1313 | GeneOrGeneProduct | denotes | apoE | ||
| T35995 | 1244-1248 | GeneOrGeneProduct | denotes | apoE | ||
| T49298 | 1195-1199 | GeneOrGeneProduct | denotes | apoE | ||
| T5611 | 1015-1019 | GeneOrGeneProduct | denotes | apoE | ||
| T23575 | 843-847 | GeneOrGeneProduct | denotes | apoE | ||
| T19350 | 730-734 | GeneOrGeneProduct | denotes | apoE | ||
| T73798 | 615-619 | GeneOrGeneProduct | denotes | apoE | ||
| T23569 | 567-571 | GeneOrGeneProduct | denotes | apoE | ||
| T18240 | 466-470 | GeneOrGeneProduct | denotes | apoE | ||
| T6 | 389-393 | GeneOrGeneProduct | denotes | apoE | ||
| T73885 | 328-332 | GeneOrGeneProduct | denotes | apoE | ||
| T4 | 310-326 | GeneOrGeneProduct | denotes | apolipoprotein E | ||
| T3 | 144-155 | GeneOrGeneProduct | denotes | Lipoprotein | ||
| T35214 | 99-110 | GeneOrGeneProduct | denotes | lipoprotein | ||
| T17448 | 18-34 | GeneOrGeneProduct | denotes | apolipoprotein E | ||
| T76702 | 1496-1499 | DiseaseOrPhenotypicFeature | denotes | LPG | C567089 | |
| T93240 | 1350-1361 | DiseaseOrPhenotypicFeature | denotes | proteinuria | D011507 | |
| T30916 | 877-880 | DiseaseOrPhenotypicFeature | denotes | LPG | C567089 | |
| T48527 | 644-647 | DiseaseOrPhenotypicFeature | denotes | LPG | C567089 | |
| T13365 | 577-580 | DiseaseOrPhenotypicFeature | denotes | LPG | C567089 | |
| T27156 | 441-444 | DiseaseOrPhenotypicFeature | denotes | LPG | C567089 | |
| T37406 | 432-435 | DiseaseOrPhenotypicFeature | denotes | LPG | C567089 | |
| T41687 | 212-220 | DiseaseOrPhenotypicFeature | denotes | thrombus | D013927 | |
| T31707 | 172-175 | DiseaseOrPhenotypicFeature | denotes | LPG | C567089 | |
| T61934 | 144-170 | DiseaseOrPhenotypicFeature | denotes | Lipoprotein glomerulopathy | C567089 | |
| T37594 | 99-125 | DiseaseOrPhenotypicFeature | denotes | lipoprotein glomerulopathy | C567089 | |
| T9467 | 1207-1215 | OrganismTaxon | denotes | patients | ||
| T89404 | 1032-1040 | OrganismTaxon | denotes | patients | ||
| T86290 | 881-889 | OrganismTaxon | denotes | patients | ||
| T96854 | 648-656 | OrganismTaxon | denotes | patients | ||
| T31995 | 497-505 | OrganismTaxon | denotes | patients | ||
| T23900 | 212-220 | OrganismTaxon | denotes | thrombus | ||
| T17546 | 762-766 | SequenceVariant | denotes | 18-T |
sentences
| Id | Subject | Object | Predicate | Lexical cue |
|---|---|---|---|---|
| TextSentencer_T1 | 0-126 | Sentence | denotes | Identification of apolipoprotein E Guangzhou (arginine 150 proline), a new variant associated with lipoprotein glomerulopathy. |
| TextSentencer_T2 | 127-143 | Sentence | denotes | BACKGROUND/AIMS: |
| TextSentencer_T3 | 144-334 | Sentence | denotes | Lipoprotein glomerulopathy (LPG) is a rare disease characterized by thrombus-like substances in markedly dilated glomerular capillaries and elevated plasma levels of apolipoprotein E (apoE). |
| TextSentencer_T4 | 335-506 | Sentence | denotes | Previous studies have shown that genetic disorders of apoE may contribute to the pathogenesis of LPG, but LPG may not be caused by apoE gene mutations in Chinese patients. |
| TextSentencer_T5 | 507-601 | Sentence | denotes | This study investigated the association of a new variant of apoE with LPG in a Chinese family. |
| TextSentencer_T6 | 602-610 | Sentence | denotes | METHODS: |
| TextSentencer_T7 | 611-671 | Sentence | denotes | The apoE gene in a family with 4 LPG patients was sequenced. |
| TextSentencer_T8 | 672-793 | Sentence | denotes | The polymerase chain reaction product of coding region of apoE exon 4 was cloned into pMD 18-T vector and then sequenced. |
| TextSentencer_T9 | 794-802 | Sentence | denotes | RESULTS: |
| TextSentencer_T10 | 803-923 | Sentence | denotes | A novel point mutation in exon 4 of the apoE gene was identified in all 4 LPG patients and 1 asymptomatic family member. |
| TextSentencer_T11 | 924-1076 | Sentence | denotes | Sequence analysis confirmed a nucleotide G to C point mutation in exon 4 (base 308) of the apoE gene in all patients and the asymptomatic family member. |
| TextSentencer_T12 | 1077-1200 | Sentence | denotes | This missense mutation denotes amino acid substitution of the proline residue for arginine residue at position 150 of apoE. |
| TextSentencer_T13 | 1201-1259 | Sentence | denotes | Those patients were all heterozygotes with apoE Guangzhou. |
| TextSentencer_T14 | 1260-1362 | Sentence | denotes | One of 2 grandsons was a heterozygous carrier of apoE Guangzhou, although he did not have proteinuria. |
| TextSentencer_T15 | 1363-1374 | Sentence | denotes | CONCLUSION: |
| TextSentencer_T16 | 1375-1500 | Sentence | denotes | The results of this study suggest that apoE (arginine 150 proline) is a novel apoE variant that etiologically related to LPG. |
| TextSentencer_T17 | 1501-1640 | Sentence | denotes | This variant (apoE Guangzhou) may cause a marked molecular conformational change of the apoE and thus impair its binding ability to lipids. |
| T1 | 0-126 | Sentence | denotes | Identification of apolipoprotein E Guangzhou (arginine 150 proline), a new variant associated with lipoprotein glomerulopathy. |
| T2 | 127-143 | Sentence | denotes | BACKGROUND/AIMS: |
| T3 | 144-334 | Sentence | denotes | Lipoprotein glomerulopathy (LPG) is a rare disease characterized by thrombus-like substances in markedly dilated glomerular capillaries and elevated plasma levels of apolipoprotein E (apoE). |
| T4 | 335-506 | Sentence | denotes | Previous studies have shown that genetic disorders of apoE may contribute to the pathogenesis of LPG, but LPG may not be caused by apoE gene mutations in Chinese patients. |
| T5 | 507-601 | Sentence | denotes | This study investigated the association of a new variant of apoE with LPG in a Chinese family. |
| T6 | 602-610 | Sentence | denotes | METHODS: |
| T7 | 611-671 | Sentence | denotes | The apoE gene in a family with 4 LPG patients was sequenced. |
| T8 | 672-793 | Sentence | denotes | The polymerase chain reaction product of coding region of apoE exon 4 was cloned into pMD 18-T vector and then sequenced. |
| T9 | 794-802 | Sentence | denotes | RESULTS: |
| T10 | 803-923 | Sentence | denotes | A novel point mutation in exon 4 of the apoE gene was identified in all 4 LPG patients and 1 asymptomatic family member. |
| T11 | 924-1076 | Sentence | denotes | Sequence analysis confirmed a nucleotide G to C point mutation in exon 4 (base 308) of the apoE gene in all patients and the asymptomatic family member. |
| T12 | 1077-1200 | Sentence | denotes | This missense mutation denotes amino acid substitution of the proline residue for arginine residue at position 150 of apoE. |
| T13 | 1201-1259 | Sentence | denotes | Those patients were all heterozygotes with apoE Guangzhou. |
| T14 | 1260-1362 | Sentence | denotes | One of 2 grandsons was a heterozygous carrier of apoE Guangzhou, although he did not have proteinuria. |
| T15 | 1363-1374 | Sentence | denotes | CONCLUSION: |
| T16 | 1375-1500 | Sentence | denotes | The results of this study suggest that apoE (arginine 150 proline) is a novel apoE variant that etiologically related to LPG. |
| T17 | 1501-1640 | Sentence | denotes | This variant (apoE Guangzhou) may cause a marked molecular conformational change of the apoE and thus impair its binding ability to lipids. |
DisGeNET
| Id | Subject | Object | Predicate | Lexical cue |
|---|---|---|---|---|
| T0 | 18-34 | gene:348 | denotes | apolipoprotein E |
| T1 | 99-125 | disease:C2673196 | denotes | lipoprotein glomerulopathy |
| T2 | 310-326 | gene:348 | denotes | apolipoprotein E |
| T3 | 172-175 | disease:C2673196 | denotes | LPG |
| T4 | 310-326 | gene:348 | denotes | apolipoprotein E |
| T5 | 144-170 | disease:C2673196 | denotes | Lipoprotein glomerulopathy |
| T6 | 310-326 | gene:348 | denotes | apolipoprotein E |
| T7 | 182-194 | disease:C0678236 | denotes | rare disease |
| R1 | T0 | T1 | associated_with | apolipoprotein E,lipoprotein glomerulopathy |
| R2 | T2 | T3 | associated_with | apolipoprotein E,LPG |
| R3 | T4 | T5 | associated_with | apolipoprotein E,Lipoprotein glomerulopathy |
| R4 | T6 | T7 | associated_with | apolipoprotein E,rare disease |
DisGeNET5_gene_disease
| Id | Subject | Object | Predicate | Lexical cue |
|---|---|---|---|---|
| 18046082-0#18#34#gene348 | 18-34 | gene348 | denotes | apolipoprotein E |
| 18046082-0#99#125#diseaseC2673196 | 99-125 | diseaseC2673196 | denotes | lipoprotein glomerulopathy |
| 18#34#gene34899#125#diseaseC2673196 | 18046082-0#18#34#gene348 | 18046082-0#99#125#diseaseC2673196 | associated_with | apolipoprotein E,lipoprotein glomerulopathy |
UBERON-AE
| Id | Subject | Object | Predicate | Lexical cue |
|---|---|---|---|---|
| PD-UBERON-AE-B_T1 | 257-279 | http://purl.obolibrary.org/obo/UBERON_0004212 | denotes | glomerular capillaries |
| PD-UBERON-AE-B_T2 | 268-279 | http://purl.obolibrary.org/obo/UBERON_0001982 | denotes | capillaries |
PubCasesHPO
| Id | Subject | Object | Predicate | Lexical cue |
|---|---|---|---|---|
| AB1 | 156-170 | HP:0100820 | denotes | glomerulopathy |
| TI1 | 111-125 | HP:0100820 | denotes | glomerulopathy |
| AB2 | 1350-1361 | HP:0000093 | denotes | proteinuria |
PubCasesORDO
| Id | Subject | Object | Predicate | Lexical cue |
|---|---|---|---|---|
| AB1 | 144-170 | ORDO:329481 | denotes | Lipoprotein glomerulopathy |
| AB2 | 172-175 | ORDO:329481 | denotes | LPG |
| TI1 | 99-125 | ORDO:329481 | denotes | lipoprotein glomerulopathy |
| AB3 | 432-435 | ORDO:329481 | denotes | LPG |
| AB4 | 441-444 | ORDO:329481 | denotes | LPG |
| AB5 | 577-580 | ORDO:329481 | denotes | LPG |
| AB6 | 644-647 | ORDO:329481 | denotes | LPG |
| AB7 | 877-880 | ORDO:329481 | denotes | LPG |
| AB8 | 1496-1499 | ORDO:329481 | denotes | LPG |
performance-test
| Id | Subject | Object | Predicate | Lexical cue |
|---|---|---|---|---|
| PD-UBERON-AE-B_T1 | 257-279 | http://purl.obolibrary.org/obo/UBERON_0004212 | denotes | glomerular capillaries |
| PD-UBERON-AE-B_T2 | 268-279 | http://purl.obolibrary.org/obo/UBERON_0001982 | denotes | capillaries |
tmVarCorpus
| Id | Subject | Object | Predicate | Lexical cue |
|---|---|---|---|---|
| T1 | 46-66 | ProteinMutation:p|SUB|R|150|P | denotes | arginine 150 proline |
| T2 | 1420-1440 | ProteinMutation:p|SUB|R|150|P | denotes | arginine 150 proline |